{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:15:45Z","timestamp":1792678545279,"version":"4.5.0"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970583"],"award-info":[{"award-number":["81970583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060138"],"award-info":[{"award-number":["82060138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>In addition to its pulmonary effects, coronavirus disease 2019 (COVID-19) has also been found to cause acute kidney injury (AKI), which has been linked to high mortality rates. In this review, we collected data from 20 clinical studies on post-COVID-19-related AKI and 97 cases of AKI associated with COVID-19 vaccination. Acute tubular injury was by far the most common finding in the kidneys of patients with COVID-19-related AKI. Among patients hospitalized for COVID-19, 34.0% developed AKI, of which 59.0%, 19.1% and 21.9% were Stages 1, 2 and 3, respectively. Though kidney disease and other adverse effects after COVID-19 vaccination overall appear rare, case reports have accumulated suggesting that COVID-19 vaccination may be associated with a risk of subsequent kidney disease. Among the patients with post-vaccination AKI, the most common pathologic findings include crescentic glomerulonephritis (29.9%), acute tubular injury (23.7%), IgA nephropathy (18.6%), antineutrophil cytoplasmic autoantibody-associated vasculitis (17.5%), minimal change disease (17.5%) and thrombotic microangiopathy (10.3%). It is important to note that crescentic glomerulonephritis appears to be more prevalent in patients who have newly diagnosed renal involvement. The proportions of patients with AKI Stages 1, 2 and 3 after COVID-19 vaccination in case reports were 30.9%, 22.7% and 46.4%, respectively. In general, clinical cases of new-onset and recurrent nephropathy with AKI after COVID-19 vaccination have a positive prognosis. In this article, we also explore the underlying pathophysiological mechanisms of AKI associated with COVID-19 infection and its vaccination by describing key renal morphological and clinical features and prognostic findings.<\/jats:p>","DOI":"10.1093\/qjmed\/hcad159","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T03:04:08Z","timestamp":1688526248000},"page":"317-337","source":"Crossref","is-referenced-by-count":11,"title":["New insights into kidney disease after COVID-19 infection and vaccination: histopathological and clinical findings"],"prefix":"10.1093","volume":"117","author":[{"given":"Yebei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University , No. 1, Minde Road , Donghu District, Nanchang 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University , No. 1, Minde Road , Donghu District, Nanchang 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University , No. 1, Minde Road , Donghu District, Nanchang 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"2024060421111175300_hcad159-B1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2024060421111175300_hcad159-B2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"2024060421111175300_hcad159-B3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial","volume":"397","author":"Emary","year":"2021","journal-title":"Lancet"},{"key":"2024060421111175300_hcad159-B4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Lebedev","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","article-title":"Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine","volume":"100","author":"D'Agati","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B6","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2024060421111175300_hcad159-B7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"2024060421111175300_hcad159-B9","doi-asserted-by":"crossref","first-page":"956158","DOI":"10.3389\/fmed.2022.956158","article-title":"Kidney injury associated with COVID-19 infection and vaccine: a narrative review","volume":"9","author":"Pacheco","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2024060421111175300_hcad159-B10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2024060421111175300_hcad159-B11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41581-020-00356-5","article-title":"COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) workgroup","volume":"16","author":"Nadim","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2024060421111175300_hcad159-B12","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/ijms23042242","article-title":"Kidney injury in COVID-19: epidemiology, molecular mechanisms and potential therapeutic targets","volume":"23","author":"Teixeira","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024060421111175300_hcad159-B13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10157-021-02123-7","article-title":"Clinical profile and outcomes of COVID-19 patients with acute kidney injury: a tertiary centre experience from South India","volume":"26","author":"Sindhu","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"2024060421111175300_hcad159-B14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12882-021-02471-2","article-title":"Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients","volume":"22","author":"Bell","year":"2021","journal-title":"BMC Nephrol"},{"key":"2024060421111175300_hcad159-B15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s40620-021-01087-x","article-title":"Acute kidney injury, a common and severe complication in hospitalized patients during the COVID-19 pandemic","volume":"34","author":"Scarpioni","year":"2021","journal-title":"J Nephrol"},{"key":"2024060421111175300_hcad159-B16","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1038\/s41598-021-94570-1","article-title":"Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"2024060421111175300_hcad159-B17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ndt\/gfab303","article-title":"Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK study: a prospective, multicentre cohort study","volume":"37","author":"Sullivan","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2024060421111175300_hcad159-B18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000517581","article-title":"The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19: data from a large cohort in Iran","volume":"46","author":"Rahimzadeh","year":"2021","journal-title":"Kidney Blood Press Res"},{"key":"2024060421111175300_hcad159-B19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamainternmed.2021.8538","article-title":"APOL1 risk variants, acute kidney injury, and death in participants with African ancestry hospitalized with COVID-19 from the million veteran program","volume":"182","author":"Hung","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2024060421111175300_hcad159-B20","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.3390\/jcm10194599","article-title":"Acute kidney disease and mortality in acute kidney injury patients with COVID-19","volume":"10","author":"Marques","year":"2021","journal-title":"J Clin Med"},{"key":"2024060421111175300_hcad159-B21","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ekir.2021.07.008","article-title":"Acute kidney injury incidence, recovery, and long-term kidney outcomes among hospitalized patients with COVID-19 and influenza","volume":"6","author":"Strohbehn","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2024060421111175300_hcad159-B22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ajkd.2021.11.004","article-title":"Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: the STOP-COVID cohort study","volume":"79","author":"Hsu","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12882-021-02557-x","article-title":"COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohort","volume":"22","author":"Jewell","year":"2021","journal-title":"BMC Nephrol"},{"key":"2024060421111175300_hcad159-B24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/ckj\/sfab021","article-title":"Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study","volume":"14","author":"Procaccini","year":"2021","journal-title":"Clin Kidney J"},{"key":"2024060421111175300_hcad159-B25","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/ckj\/sfab071","article-title":"Acute kidney injury in COVID-19: multicentre prospective analysis of registry data","volume":"14","author":"Wan","year":"2021","journal-title":"Clin Kidney J"},{"key":"2024060421111175300_hcad159-B26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B27","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.3390\/jcm10235522","article-title":"Kidney dysfunction and its progression in patients hospitalized duo to COVID-19: contribution to the clinical course and outcomes","volume":"10","author":"Kilis-Pstrusinska","year":"2021","journal-title":"J Clin Med"},{"key":"2024060421111175300_hcad159-B28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.ajkd.2020.12.007","article-title":"The association of COVID-19 with acute kidney injury independent of severity of illness: a multicenter cohort study","volume":"77","author":"Moledina","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11255-022-03454-4","article-title":"Acute kidney injury in coronavirus infectious disease: a study of incidence, risk factors, and prognosis during the first wave of the disease in Brazil","volume":"55","author":"Magalhaes","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"2024060421111175300_hcad159-B30","doi-asserted-by":"crossref","first-page":"101724","DOI":"10.1016\/j.eclinm.2022.101724","article-title":"Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study","volume":"55","author":"Tan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2024060421111175300_hcad159-B31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/pathogens11111272","article-title":"Acute kidney injury in non-intensive care unit (ICU) hospitalizations for coronavirus disease (COVID-19)","volume":"11","author":"Fabrizi","year":"2022","journal-title":"Pathogens"},{"key":"2024060421111175300_hcad159-B32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2020050615","article-title":"AKI in hospitalized patients with COVID-19","volume":"32","author":"Chan","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024060421111175300_hcad159-B33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nefroe.2021.02.006","article-title":"Acute kidney failure in patients admitted due to COVID-19","volume":"41","author":"Tarragon","year":"2021","journal-title":"Nefrologia (Engl Ed)"},{"key":"2024060421111175300_hcad159-B34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2024060421111175300_hcad159-B36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/medicina58030443","article-title":"Evolving risk of acute kidney injury in COVID-19 hospitalized patients: a single center retrospective study","volume":"58","author":"Algahtani","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"2024060421111175300_hcad159-B37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"2024060421111175300_hcad159-B38","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4103\/1319-2442.352414","article-title":"Acute kidney injury associated with coronavirus disease 2019 - one year later, what do We know so far?","volume":"32","author":"Gharge","year":"2021","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2024060421111175300_hcad159-B39","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1159\/000511946","article-title":"Association of proteinuria and hematuria with acute kidney injury and mortality in hospitalized patients with COVID-19","volume":"45","author":"Chaudhri","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"2024060421111175300_hcad159-B40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00134-019-05869-7","article-title":"Lung-kidney interactions in critically ill patients: consensus report of the acute disease quality initiative (ADQI) 21 workgroup","volume":"46","author":"Joannidis","year":"2020","journal-title":"Intensive Care Med"},{"key":"2024060421111175300_hcad159-B41","author":"Li","year":"2020"},{"key":"2024060421111175300_hcad159-B42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/j.ajkd.2021.06.008","article-title":"Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report","volume":"78","author":"Leclerc","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B43","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3346\/jkms.2021.36.e218","article-title":"New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review","volume":"36","author":"Lim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"2024060421111175300_hcad159-B44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ajkd.2021.05.003","article-title":"An additional case of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Maas","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.kint.2021.05.007","article-title":"Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine","volume":"100","author":"Holzworth","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.kint.2021.06.004","article-title":"Post-vaccinal minimal change disease","volume":"100","author":"Weijers","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/vaccines10020302","article-title":"New-onset kidney diseases after COVID-19 vaccination: a case series","volume":"10","author":"Lim","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2024060421111175300_hcad159-B48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/qjmed\/hcac094","article-title":"Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine","volume":"115","author":"Park","year":"2022","journal-title":"QJM"},{"key":"2024060421111175300_hcad159-B49","article-title":"Pediatric minimal change disease and AKI following the Pfizer-BioNTech COVID-19 vaccine: causal or incidental correlation?","volume":"39","author":"Annicchiarico Petruzzelli","year":"2022","journal-title":"G Ital Nefrol"},{"key":"2024060421111175300_hcad159-B50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nep.13995","article-title":"Report of two cases of minimal change disease following vaccination for COVID-19","volume":"27","author":"Baskaran","year":"2022","journal-title":"Nephrology (Carlton)"},{"key":"2024060421111175300_hcad159-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20543581211058271","article-title":"Minimal change disease after first dose of Pfizer-BioNTech COVID-19 vaccine: a case report and review of minimal change disease related to COVID-19 vaccine","volume":"8","author":"Hanna","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"2024060421111175300_hcad159-B52","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ckj\/sfab252","article-title":"Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?","volume":"15","author":"Psyllaki","year":"2022","journal-title":"Clin Kidney J"},{"key":"2024060421111175300_hcad159-B53","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40620-021-01091-1","article-title":"Minimal change disease following vaccination for SARS-CoV-2","volume":"34","author":"Mancianti","year":"2021","journal-title":"J Nephrol"},{"key":"2024060421111175300_hcad159-B54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.kint.2021.07.016","article-title":"A case of membranous nephropathy following Pfizer-BioNTech mRNA vaccination against COVID-19","volume":"100","author":"Da","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/vaccines11010080","article-title":"Membranous nephropathy following full-dose of inactivated SARS-CoV-2 virus vaccination: a case report and literature review","volume":"11","author":"Thammathiwat","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2024060421111175300_hcad159-B56","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.5114\/aoms\/153477","article-title":"Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine","volume":"18","author":"Huang","year":"2022","journal-title":"Arch Med Sci"},{"key":"2024060421111175300_hcad159-B57","author":"Fernandez","year":"2021"},{"key":"2024060421111175300_hcad159-B58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5414\/CN110794","article-title":"De novo or recurrent glomerulonephritis and acute tubulointerstitial nephritis after COVID-19 vaccination: a report of six cases from a single center","volume":"97","author":"Schaubschlager","year":"2022","journal-title":"Clin Nephrol"},{"key":"2024060421111175300_hcad159-B59","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.kint.2021.06.011","article-title":"Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy","volume":"100","author":"Kudose","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2021.05.009","article-title":"Is COVID-19 vaccination unmasking glomerulonephritis?","volume":"100","author":"Tan","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.kint.2021.06.032","article-title":"IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine","volume":"100","author":"Hanna","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.kint.2021.05.016","article-title":"De novo vasculitis after mRNA-1273 (Moderna) vaccination","volume":"100","author":"Anderegg","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ckj\/sfab284","article-title":"Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines","volume":"15","author":"Ritter","year":"2022","journal-title":"Clin Kidney J"},{"key":"2024060421111175300_hcad159-B64","doi-asserted-by":"crossref","first-page":"3000605221129674","DOI":"10.1177\/03000605221129674","article-title":"Newly-diagnosed immunoglobulin a nephropathy with increased plasma galactose-deficient-IgA(1) antibody associated with mRNA COVID-19 vaccination: a case report","volume":"50","author":"Chen","year":"2022","journal-title":"J Int Med Res"},{"key":"2024060421111175300_hcad159-B65","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.ekir.2021.06.007","article-title":"Letter regarding: \"a case of gross hematuria and IgA nephropathy Flare-Up following SARS-CoV-2 vaccination\"","volume":"6","author":"Park","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2024060421111175300_hcad159-B66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s13730-022-00695-1","article-title":"Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review","volume":"11","author":"Sugita","year":"2022","journal-title":"CEN Case Rep"},{"key":"2024060421111175300_hcad159-B67","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.kint.2021.05.022","article-title":"Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy","volume":"100","author":"Perrin","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12882-022-02769-9","article-title":"IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report","volume":"23","author":"Watanabe","year":"2022","journal-title":"BMC Nephrol"},{"key":"2024060421111175300_hcad159-B69","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.kint.2021.06.033","article-title":"Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine","volume":"100","author":"Gillion","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00467-022-05681-4","article-title":"A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination","volume":"38","author":"Kim","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2024060421111175300_hcad159-B71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.kint.2021.06.006","article-title":"Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination","volume":"100","author":"Sacker","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000525737","article-title":"Anti-GBM disease after Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccination: a report of two cases","volume":"12","author":"Coorey","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"2024060421111175300_hcad159-B73","doi-asserted-by":"crossref","first-page":"e246841","DOI":"10.1136\/bcr-2021-246841","article-title":"Acute interstitial nephritis after COVID-19 vaccination","volume":"15","author":"Tan","year":"2022","journal-title":"BMJ Case Rep"},{"key":"2024060421111175300_hcad159-B74","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/IJNRD.S345898","article-title":"A case of acute interstitial nephritis after two doses of the BNT162b2 SARS-CoV-2 vaccine","volume":"14","author":"Mira","year":"2021","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2024060421111175300_hcad159-B75","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/ckj\/sfab155","article-title":"Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine","volume":"14","author":"Unver","year":"2021","journal-title":"Clin Kidney J"},{"key":"2024060421111175300_hcad159-B76","doi-asserted-by":"crossref","first-page":"2059308","DOI":"10.1080\/21645515.2022.2059308","article-title":"Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine","volume":"18","author":"Choi","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2024060421111175300_hcad159-B77","doi-asserted-by":"crossref","first-page":"e12578","DOI":"10.1002\/rth2.12578","article-title":"Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report","volume":"5","author":"Al Rawahi","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"2024060421111175300_hcad159-B78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajem.2021.05.001","article-title":"Thrombotic thrombocytopenic purpura after Ad26.COV2-S vaccination","volume":"49","author":"Yocum","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2024060421111175300_hcad159-B79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12882-021-02616-3","article-title":"First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report","volume":"22","author":"Osmanodja","year":"2021","journal-title":"BMC Nephrol"},{"key":"2024060421111175300_hcad159-B80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jha2.342","article-title":"Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination","volume":"3","author":"Alislambouli","year":"2022","journal-title":"EJHaem"},{"key":"2024060421111175300_hcad159-B81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2169\/internalmedicine.8568-21","article-title":"Acquired thrombotic thrombocytopenic purpura following BNT162b2 mRNA coronavirus disease vaccination in a Japanese patient","volume":"61","author":"Yoshida","year":"2022","journal-title":"Intern Med"},{"key":"2024060421111175300_hcad159-B82","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00277-021-04584-y","article-title":"Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine","volume":"101","author":"Ruhe","year":"2022","journal-title":"Ann Hematol"},{"key":"2024060421111175300_hcad159-B83","first-page":"e16619","article-title":"Thrombotic thrombocytopenic purpura presentation in an elderly gentleman following COVID vaccine circumstances","volume":"13","author":"Chamarti","year":"2021","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B84","article-title":"Atypical hemolytic uremic syndrome occurring after receipt of mRNA-1273 COVID-19 vaccine booster: a case report","author":"Claes","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B85","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/qjmed\/hcab284","article-title":"Lupus nephritis flare post Moderna mRNA-1273 coronavirus vaccine","volume":"114","author":"Sekar","year":"2022","journal-title":"QJM"},{"key":"2024060421111175300_hcad159-B86","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.kint.2022.01.013","article-title":"New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination","volume":"101","author":"Kim","year":"2022","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B87","doi-asserted-by":"crossref","first-page":"e934399","DOI":"10.12659\/AJCR.934399","article-title":"Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: a case report","volume":"23","author":"Al-Rasbi","year":"2022","journal-title":"Am J Case Rep"},{"key":"2024060421111175300_hcad159-B88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/87551225221093944","article-title":"A possible case of COVID-19 booster vaccine-associated rhabdomyolysis and acute kidney injury","volume":"38","author":"Unger","year":"2022","journal-title":"J Pharm Technol"},{"key":"2024060421111175300_hcad159-B89","first-page":"e25199","article-title":"Severe rhabdomyolysis complicated with acute kidney injury required renal replacement therapy after Pfizer COVID-19 vaccine \u202f","volume":"14","author":"Banamah","year":"2022","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B90","article-title":"Leukocytoclastic vasculitis and acute renal failure following inactivated SARS-CoV-2 vaccine","author":"Missoum","year":"2021","journal-title":"Nephrol Ther"},{"key":"2024060421111175300_hcad159-B91","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41541-022-00445-5","article-title":"Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report","volume":"7","author":"Vnu\u010d\u00e1k","year":"2022","journal-title":"NPJ Vaccines"},{"key":"2024060421111175300_hcad159-B92","first-page":"5122228","article-title":"Minimal change nephrotic syndrome with acute kidney injury after the administration of Pfizer-BioNTech COVID-19 vaccine","volume":"2023","author":"Gulumsek","year":"2023","journal-title":"Case Rep Infect Dis"},{"key":"2024060421111175300_hcad159-B93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12882-023-03169-3","article-title":"Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report","volume":"24","author":"Morimoto","year":"2023","journal-title":"BMC Nephrol"},{"key":"2024060421111175300_hcad159-B94","first-page":"e37569","article-title":"Cardiac tamponade as a complication of microscopic polyangiitis: a case associated with a COVID-19 mRNA vaccine","volume":"15","author":"Avalos","year":"2023","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B95","first-page":"e35305","article-title":"Focal crescentic glomerulonephritis following COVID-19 viral vector vaccination","volume":"15","author":"Wisnik-Rainville","year":"2023","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B96","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/vaccines11020464","article-title":"Renal biopsy diagnosis of acute tubular injury after Pfizer-BioNTech COVID-19 vaccination: a case report","volume":"11","author":"Soma","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2024060421111175300_hcad159-B97","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/vaccines11030679","article-title":"End-stage kidney disease resulting from atypical hemolytic uremic syndrome after receiving AstraZeneca SARS-CoV-2 vaccine: a case report","volume":"11","author":"Tawhari","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2024060421111175300_hcad159-B98","doi-asserted-by":"crossref","first-page":"1003332","DOI":"10.3389\/fmed.2022.1003332","article-title":"ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: is there a causal relationship? A case report","volume":"9","author":"Zamoner","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2024060421111175300_hcad159-B99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4103\/ijn.ijn_352_21","article-title":"Post COVID vaccination (COVAXIN-BB152 V) pauci-immune crescentic glomerulonephritis","volume":"32","author":"Bansal","year":"2022","journal-title":"Indian J Nephrol"},{"key":"2024060421111175300_hcad159-B100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B101","first-page":"e19616","article-title":"De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19","volume":"13","author":"Feghali","year":"2021","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B102","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2021.07.026","article-title":"A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?","volume":"100","author":"Villa","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B103","first-page":"e30565","article-title":"Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis as a possible side effect of COVID-19 vaccination","volume":"14","author":"Noel","year":"2022","journal-title":"Cureus"},{"key":"2024060421111175300_hcad159-B104","doi-asserted-by":"crossref","first-page":"762006","DOI":"10.3389\/fimmu.2021.762006","article-title":"Case report: ANCA-Associated vasculitis presenting with rhabdomyolysis and Pauci-Immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination","volume":"12","author":"Hakroush","year":"2021","journal-title":"Front Immunol"},{"key":"2024060421111175300_hcad159-B105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024060421111175300_hcad159-B106","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3346\/jkms.2022.37.e154","article-title":"Microscopic polyangiitis following mRNA COVID-19 vaccination: a case report","volume":"37","author":"So","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2024060421111175300_hcad159-B107","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.ekir.2021.08.012","article-title":"Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis following the Pfizer-BioNTech COVID-19 vaccine","volume":"6","author":"Dube","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2024060421111175300_hcad159-B108","doi-asserted-by":"crossref","first-page":"20406223221125708","DOI":"10.1177\/20406223221125708","article-title":"ANCA-associated vasculitis following the CoronaVac vaccination","volume":"13","author":"Ma","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"2024060421111175300_hcad159-B109","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.3346\/jkms.2022.37.e204","article-title":"A case report of MPO-ANCA-associated vasculitis following heterologous mRNA1273 COVID-19 booster vaccination","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2024060421111175300_hcad159-B110","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.2169\/internalmedicine.9807-22","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis after COVID-19 vaccination with Pfizer-BioNTech","volume":"61","author":"Suzuki","year":"2022","journal-title":"Intern Med"},{"key":"2024060421111175300_hcad159-B111","doi-asserted-by":"crossref","first-page":"e243888","DOI":"10.1136\/bcr-2021-243888","article-title":"Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)","volume":"14","author":"Nune","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2024060421111175300_hcad159-B112","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.kint.2021.05.001","article-title":"Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination","volume":"100","author":"Aydin","year":"2021","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B113","first-page":"531","article-title":"An unusually \"complex\" glomerulonephritis","volume":"35","author":"Martinez-Zayas","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2024060421111175300_hcad159-B114","doi-asserted-by":"crossref","first-page":"586589","DOI":"10.3389\/fphys.2021.586589","article-title":"Pathogenesis of acute kidney injury in coronavirus disease 2019","volume":"12","author":"Qian","year":"2021","journal-title":"Front Physiol"},{"key":"2024060421111175300_hcad159-B115","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1681\/ASN.2020111546","article-title":"Human kidney spheroids and monolayers provide insights into SARS-CoV-2 renal interactions","volume":"32","author":"Omer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024060421111175300_hcad159-B116","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12890-020-01305-5","article-title":"The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study","volume":"20","author":"Sang","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024060421111175300_hcad159-B117","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertens Res"},{"key":"2024060421111175300_hcad159-B118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"2024060421111175300_hcad159-B119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol Ther"},{"key":"2024060421111175300_hcad159-B120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med"},{"key":"2024060421111175300_hcad159-B121","doi-asserted-by":"crossref","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","article-title":"ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19","volume":"131","author":"Dong","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2024060421111175300_hcad159-B122","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/ijerph18010284","article-title":"The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection","volume":"18","author":"Qi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2024060421111175300_hcad159-B123","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1128\/JVI.00096-08","article-title":"Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein","volume":"82","author":"Pacciarini","year":"2008","journal-title":"J Virol"},{"key":"2024060421111175300_hcad159-B124","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s42399-020-00529-0","article-title":"SARS-CoV-2-related kidney injury: current concern and challenges","volume":"2","author":"Cheng","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"2024060421111175300_hcad159-B125","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.2023.3546","article-title":"Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor-Biased ligand in adults with COVID-19: two randomized clinical trials","volume":"329","author":"Self","year":"2023","journal-title":"JAMA"},{"key":"2024060421111175300_hcad159-B126","doi-asserted-by":"crossref","first-page":"e222735","DOI":"10.1001\/jamanetworkopen.2022.2735","article-title":"Efficacy of losartan in hospitalized patients with COVID-19-induced lung injury: a randomized clinical trial","volume":"5","author":"Puskarich","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024060421111175300_hcad159-B127","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"2024060421111175300_hcad159-B128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024060421111175300_hcad159-B129","doi-asserted-by":"crossref","first-page":"e2019209","DOI":"10.1001\/jamanetworkopen.2020.19209","article-title":"Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement","volume":"3","author":"Ostermann","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024060421111175300_hcad159-B130","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.3390\/ijms232012514","article-title":"Update on innate immunity in acute kidney Injury-Lessons taken from COVID-19","volume":"23","author":"Musial","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024060421111175300_hcad159-B131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12959-022-00384-0","article-title":"Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb J"},{"key":"2024060421111175300_hcad159-B132","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.accpm.2020.06.006","article-title":"Activation of the renin-angiotensin-aldosterone system is associated with acute kidney injury in COVID-19","volume":"39","author":"Dudoignon","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2024060421111175300_hcad159-B133","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2024060421111175300_hcad159-B134","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfu302","article-title":"CD147 (EMMPRIN\/Basigin) in kidney diseases: from an inflammation and immune system viewpoint","volume":"30","author":"Kosugi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2024060421111175300_hcad159-B135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.yjmcc.2010.05.007","article-title":"EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K\/Akt\/IKK\/NF-kappaB andMKK7\/JNK\/AP-1 signaling","volume":"49","author":"Venkatesan","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2024060421111175300_hcad159-B136","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024060421111175300_hcad159-B137","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00134-008-1124-6","article-title":"Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors","volume":"34","author":"Cantaluppi","year":"2008","journal-title":"Intensive Care Med"},{"key":"2024060421111175300_hcad159-B138","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MCC.0000000000000153","article-title":"Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies","volume":"20","author":"Zarbock","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"2024060421111175300_hcad159-B139","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00134-010-2050-y","article-title":"Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients","volume":"37","author":"Darmon","year":"2011","journal-title":"Intensive Care Med"},{"key":"2024060421111175300_hcad159-B140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2119\/2008-00006.Legrand","article-title":"Renal hypoxia and dysoxia after reperfusion of the ischemic kidney","volume":"14","author":"Legrand","year":"2008","journal-title":"Mol Med"},{"key":"2024060421111175300_hcad159-B141","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41581-020-0284-7","article-title":"Kidney involvement in COVID-19 and rationale for extracorporeal therapies","volume":"16","author":"Ronco","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2024060421111175300_hcad159-B142","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000259585","article-title":"Mechanical ventilation and the kidney","volume":"29","author":"Koyner","year":"2010","journal-title":"Blood Purif"},{"key":"2024060421111175300_hcad159-B143","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S2213-2600(20)30328-3","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study","volume":"8","author":"Schmidt","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024060421111175300_hcad159-B144","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5527\/wjn.v11.i3.105","article-title":"Multidisciplinary basic and clinical research of acute kidney injury with COVID-19: pathophysiology, mechanisms, incidence, management and kidney transplantation","volume":"11","author":"Wishahi","year":"2022","journal-title":"World J Nephrol"},{"key":"2024060421111175300_hcad159-B145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.2020060804","article-title":"COVID-19-associated glomerular disease","volume":"32","author":"Shetty","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024060421111175300_hcad159-B146","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2024060421111175300_hcad159-B147","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"2024060421111175300_hcad159-B148","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/s41467-020-18058-8","article-title":"A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction","volume":"11","author":"Ejemel","year":"2020","journal-title":"Nat Commun"},{"key":"2024060421111175300_hcad159-B149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/qjmed\/hcac287","article-title":"New insights into the mucosal immune pathogenesis of IgA nephropathy from the perspective of COVID-19 vaccination","volume":"116","author":"Ma","year":"2023","journal-title":"QJM"},{"key":"2024060421111175300_hcad159-B150","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4103\/1319-2442.168676","article-title":"Membranous nephropathy and severe acute kidney injury following influenza vaccination","volume":"26","author":"Patel","year":"2015","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2024060421111175300_hcad159-B151","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(20)30987-7","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024060421111175300_hcad159-B152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun"},{"key":"2024060421111175300_hcad159-B153","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"2024060421111175300_hcad159-B154","first-page":"3","article-title":"The mosaic of autoimmunity: genetic factors involved in autoimmune diseases\u20132008","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"2024060421111175300_hcad159-B155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2024060421111175300_hcad159-B156","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1002\/jmv.27077","article-title":"Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state","volume":"93","author":"Henry","year":"2021","journal-title":"J Med Virol"},{"key":"2024060421111175300_hcad159-B157","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"2024060421111175300_hcad159-B158","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-021-04914-3","article-title":"ANCA-associated vasculitis after COVID-19","volume":"41","author":"Izci Duran","year":"2021","journal-title":"Rheumatol Int"},{"key":"2024060421111175300_hcad159-B159","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/imr.12375","article-title":"Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology","volume":"269","author":"Pelka","year":"2016","journal-title":"Immunol Rev"},{"key":"2024060421111175300_hcad159-B160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2024060421111175300_hcad159-B161","first-page":"157","article-title":"Acute kidney injury in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study","volume":"41","author":"Xiao","year":"2021","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2024060421111175300_hcad159-B162","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.kint.2020.07.019","article-title":"SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule","volume":"98","author":"Werion","year":"2020","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B163","doi-asserted-by":"crossref","first-page":"101152","DOI":"10.1016\/j.eclinm.2021.101152","article-title":"Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-Centre double-blind phase 2 trial","volume":"41","author":"Tornling","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2024060421111175300_hcad159-B164","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024060421111175300_hcad159-B165","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.kint.2022.08.021","article-title":"Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased","volume":"102","author":"Diebold","year":"2022","journal-title":"Kidney Int"},{"key":"2024060421111175300_hcad159-B166","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfac292","article-title":"Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines","volume":"38","author":"Cheng","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2024060421111175300_hcad159-B167","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1681\/ASN.2022030258","article-title":"A population-based analysis of the risk of glomerular disease relapse after COVID-19 vaccination","volume":"33","author":"Canney","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2024060421111175300_hcad159-B168","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/vaccines10050706","article-title":"Association of current active illnesses and severe acute kidney injury after COVID-19 vaccines: a real-world study","volume":"10","author":"Chen","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2024060421111175300_hcad159-B169","doi-asserted-by":"crossref","first-page":"e0261958","DOI":"10.1371\/journal.pone.0261958","article-title":"COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in Sao Paulo, Brazil","volume":"17","author":"Samaan","year":"2022","journal-title":"PLoS One"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcad159\/50961944\/hcad159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/117\/5\/317\/58086859\/hcad159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/117\/5\/317\/58086859\/hcad159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T01:28:22Z","timestamp":1717550902000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/117\/5\/317\/7218935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":169,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,7,4]]},"published-print":{"date-parts":[[2024,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcad159","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2023,7,4]]}}}